Asthma in pediatric patients: unmet need and therapeutic options.
Maykut
Robert
R
Novartis Pharma AG, Basel, Switzerland. robert.maykut@novartis.com
Zeiger
Robert S
RS
Brown
Mark A
MA
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D002648:Child; D015897:Comorbidity; D017281:Cost of Illness; D018450:Disease Progression; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data* / Q000639:trends*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D007167:Immunotherapy / Q000379:methods; D011379:Prognosis; D011788:Quality of Life; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D018927:Anti-Asthmatic Agents; D007073:Immunoglobulin E